{"retracted":false,"update":{"timestamp":1485216000000,"doi":"10.1007/s11523-017-0475-8","type":"correction"},"doi":"10.1007/s11523-015-0364-y","journal":"Targeted Oncology","publisher":"Springer Nature","title":"Erratum to: A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines"}
